Resistant hypertension in a patient with primary aldosteroninsm. An unusual clinical presentation
DOI:
https://doi.org/10.51481/amc.v61i2.1032Keywords:
Resistant hypertension, Plasma aldosterone, Suprarenal adenoma, Primary aldosteronismAbstract
In this report we present a case of a patient with resistant hypertension treated with triple antihypertensive medication. The patient suffered of sudden episodes of nocturnal hypertension, headache, dyspnoea, palpitations, precordial pain and a left suprarenal mass was found in the abdominal ultrasound. These findings suggested endocrine hypertension due to pheochromocytoma. However, the laboratory tests showed hypokalemia, high plasma aldosterone concentrations and suppressed plasma renin activity. This results were consistent with primary aldosteronism. After the laparoscopic removal of the suprarenal adenoma blood pressure, plasma aldosterone concentrations and plasma renine activity returned to normal.
Downloads
References
Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008; 117:e510-e526.
2011 Writing Group Members, 2005 Writing Committtee Members ACCF/ AHA Task Force Members. 2011 ACCF/AHA Focused Update of the Guideline for the Managment of patients with peripheral artery disease Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation 2011; 124:2020-2045.
Bravo EL, Tagle R. Pheochromocytoma: State -of-the-art and future prospects. Endocr Rev 2003; 24:539-553
Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Inter Med 1993; 153:2125-2129.
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: Case detection, diagnosis and treatment: An Endocrine Society Practice Guideline. J Clin End Metab 2016:101:1889-1916.
Schwartz GL, Turner ST, Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005; 51:386-394
Funder JW Primary aldosteronism. J Clin Endo Metabolism 2015; 100: 28532855.
Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and Clinical Manifestation of Primary Aldosteronism in Primary Care Practice. J AM Coll Cardiol 2017; 69:1811-1820.
Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, et al. Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. J Clin Endocrinol Metab 2016; 101: 2826-2835.
Markou A, Sertedaki A, Kaltsas G, Androulakis II, Marakaki C, Pappa T, et al. Stress/induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension. J Clin Endocrinolo Metab 2015; 100:2857-286.
Galti SJ. Primary aldosteronism: challenges in diagnosis and management. Endocrinol Metab Clin North Am. 2015;44:355-369.
Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosternonism type I. J Clin Endocrinol Metab 2005;90: 5070-5076.
Downloads
Published
Versions
- 2019-04-29 (2)
- 2019-04-29 (1)
Issue
Section
License
Copyright (c) 2019 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
